Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Android | RSS
After a recent announcement from Novo Nordisk I cleared my schedule to record this episode with Dr. Todd Hobbs, Chief Medical Officer for North America and Ken Inchausti, Senior Director of Corporate Communications. In this open discussion they share resources and cost saving programs, details about insulin production, insulin trials and what’s on the horizon for insulin therapies. I learned SO much about a drug I’ve been taking for decades!
Thank you everyone for submitting your questions for this episode. Please feel free to contact me any time if there is someone you would like me to interview.
WATCH ON YOUTUBE:
SHOW NOTES:
- Novocare.com
- Hotline: 844.NOVO4ME (M-F, 8:30am-11:00pm, Sat, 11:00am-7:00pm)
- My $99 insulin (three vials or two pack of pens)
- Generic Insulin/Unbranded Biologic (50% regular price)
- Immediate Supply Option
- Enhanced Patient Assistance – If you use a Novo Nordisk insulin and lost health insurance coverage because of a change in job status due to COVID-19, you may be eligible to enroll in their program and receive insulin free-of-charge for 90 days. Assistance can be extended to the end of 2020, after the 90-day window, for otherwise eligible patients who have been denied Medicaid coverage.
Amber Clour
Amber Clour was born and raised in Norman, Oklahoma. 21 days after her eighth birthday, she was rushed to Children’s Hospital where she spent two weeks learning how to live life with Type 1 diabetes. She has embraced the thought of being a #walkingscienceproject and hopes to score an A+ for her efforts to maintain a stable BG while living life to the fullest - whatever that means.